Resources - Webinars

Agilent Cell Analysis Virtual Events - On Demand

November 12, 2020

The next generation of vaccines and anti-viral therapies require a new generation of analysis tools.

Presenters: Dr. Peter Mullen, Assistant Project Scientist, University of California, Los Angeles; Dr. Kevin Bittman, Field Applications Scientist, Cell Analysis Division, Agilent; Dr. Yama Abassi, Head of Strategic Business Development, Cell Analysis Division, Agilent; Dr. Kristen Olson, Imaging Specialist and Field Applications Scientist, BioTek Instruments, a part of Agilent.

Research advancing our understanding of host-pathogen and host-immune response to virus infection is critical and timely under the current global pandemic.

Discover Agilent’s new end-to-end solutions for virology disease research, drug discovery and vaccine development, enabling translational researchers and developers to address present and future challenges in global human health and infectious disease.

Register for our Virtual Roadshow, where we will be joined by Dr. Peter Mullen from the University of California, Los Angeles. Learn also from Agilent product experts who will showcase relevant product lines and assays, including Seahorse XF technology, xCELLigence RTCA, NovoCyte Flow Cytometry & BioTek Instruments, supported by published application examples from the field.
 

WATCH THE RECORDING


November 24, 2020

The next generation of vaccines and anti-viral therapies require a new generation of analysis tools.

Presenters: Dr. Alexander Lercher, Postdoctoral Fellow, Rockefeller University, Charlie Rice Lab, New York City, USA; Dr. Andreas Bergthaler, Principal Investigator, CeMM of the Austrian Academy of Sciences, Vienna, Austria; Dr. Daniel Gebhard, Product Specialist, Germany, Austria, Cell Analysis Division, Agilent; Dr. Silke Schwengberg, Country Manager Germany, Austria, Switzerland, Cell Analysis Division, Agilent, Dr. Kristen Olson, Imaging Specialist and Field Applications Scientist, BioTek Instruments, a part of Agilent.

Research advancing our understanding of host-pathogen and host-immune response to virus infection is critical and timely under the current global pandemic.

Discover Agilent’s new end-to-end solutions for virology disease research, drug discovery and vaccine development, enabling translational researchers and developers to address present and future challenges in global human health and infectious disease.

Register for our Virtual Roadshow, where we will be joined by Dr. Andreas Bergthaler from the Research Center for Molecular Medicine of the Austrian Academy of Sciences and Dr. Alexander Lercher, Postdoctoral Fellow. Rockefeller University, Charlie Rice Lab, New York City, USA. Learn also from Agilent product experts who will showcase relevant product lines and assays, including Seahorse XF technology, xCELLigence RTCA, NovoCyte Flow Cytometry & BioTek Instruments, supported by published application examples from the field.
 

WATCH THE RECORDING

link